Stenting as prophylaxis for vulnerable plaques?
Patients with vulnerable plaques have a significantly greater risk of major adverse cardiovascular events (MACE), but prophylactic PCI* of these non-flow-limiting lipid-rich plaques substantially expands the lumen area, which may prevent future clinical events, according to the PROSPECT II and PROSPECT ABSORB studies presented at TCT 2020.